Search Results 101-110 of 13168 for pharmacogenetics
Ortega researches landmark whole-genome studies in underrepresented minorities to discover new, ancestry-specific pharmacogenetic variants. Significance to ...
study expands previous pharmacogenetic research completed by the Mayo ... Applying pharmacogenetics for an individualized treatment approach on a ...
Johnson Genomics of Addiction Program brings together a multidisciplinary, integrated group of clinicians and scientists to better understand how genetic ...
Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet. Clinical Trials. Largest ...
... pharmacogenetics component of this study. Refusal to give consent for this component does not exclude a participant from participation in this clinical ...
Researchers in the fields of statistical genetics and genetic epidemiology develop new methods and improve existing workflows to identify genetic risk factors ...
This study recently used pharmacogenetic (PGx) data on 11,000 subjects within the Mayo Clinic Biobank as part of the Right Drug, Right Dose, Right Time ...
Largest pharmacogenetic clinical ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The American Heart Association gives guidance on CYP2C19 genetic-guided testing for prescribing blood thinner drugs. A Mayo Clinic cardiologist chaired the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Last chance! Your gift today has 5X the power to fuel medical progress using AI.